Brief: Eterna Therapeutics Inc - Co Entered Into An Exclusive Amended And Restated License Agreement With Factor Bioscience Limited

Ernexa Therapeutics

16/11/2023 21:56

Nov 16 (Reuters) - Eterna Therapeutics Inc  ERNA.O :
    * ETERNA THERAPEUTICS INC - ON NOVEMBER 14, CO ENTERED INTO
AN
EXCLUSIVE AMENDED AND RESTATED LICENSE AGREEMENT WITH FACTOR
BIOSCIENCE LIMITED
    * ETERNA THERAPEUTICS INC - AMENDED AGREEMENT REPLACE IN ITS
ENTIRETY EXCLUSIVE LICENSE AGREEMENT DATED FEBRUARY 20, 2023
    * ETERNA THERAPEUTICS INC - AMENDED AGREEMENT REDUCES
TERMINATION
RIGHTS OF FACTOR UNDER A&R AGREEMENT

Further company coverage:  ERNA.O 

 ((Reuters.Briefs@thomsonreuters.com;))